Capturing and amplifying impurities from recombinant therapeutic proteins via combinatorial peptide libraries: A proteomic approach

Current Pharmaceutical Biotechnology

Volumn 12, Issue 10, 2011, Pages 1537-1547

  Righetti, Pier Giorgio ^a   Boschetti, Egisto ^a   Fasoli, Elisa ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

Combinatorial peptide ligand libraries; Host protein contaminants; Low abundance proteome; rDNA proteins; Trace impurities

Indexed keywords

FOOD ADDITIVE; HEXAPEPTIDE; PEPTIDE LIBRARY; RECOMBINANT DNA;

COMBINATORIAL LIBRARY; DRUG IMPURITY; HOST CELL; PROTEOMICS; REVIEW; SOLID PHASE EXTRACTION;

EID: 80053541929     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798357285     Document Type: Review

References (74)

1. Whitmire, M.L.; Eaton, L.C. An immuno-ligand assay for quantitationof process specific Escherichia coli host cell contaminant proteinsin a recombinant bovine somatotropin. J. Immunoassay, 1997,18, 49-65.
2. Garke, G.; Deckwer, W.D.; Anspach, F.B. Preparative two-steppurification of recombinant human basic fibroblast growth factorfrom high-cell-density cultivation of Escherichia coli. J. Chromatogr.B, 2000, 737, 25-38.
3. Dutta, S.; Lalitha, P.V.; Ware, L.A.; Barbosa, A.; Moch, J.K.;Vassell, M.A.; Fileta, B.B.; Kitov, S.; Kolodny, N.; Heppner, D.G.; Haynes, J.D.; Lanar, D.E. Purification, characterization, and immunogenicityof the refolded ectodomain of the Plasmodium falciparumapical membrane antigen 1 expressed in Escherichia coli. Infect. Immun., 2002, 70, 3101-3110.
4. Hewitt, L.; McDonnell, J.M. Screening and optimizing proteinproduction in E. coli. Methods Mol. Biol., 2004, 278, 1-16.
5. Persson, J.; Lester, P. Purification of antibody and antibodyfragmentfrom E. coli homogenate using 6,9-diamino-2-ethoxyacridine lactate as precipitation agent. Biotechnol. Bioeng.,2004, 87, 424-434.
6. Piefer, A.J.; Jonsson, C.B. A comparative study of the human Tcellleukemia virus type 2 integrase expressed in and purified fromEscherichia coli and Pichia pastoris. Protein Expr. Purif., 2002,25, 291-299.
7. Steinlein, L.M.; Graf, T.N.; Ikeda, R.A. Production and purificationof N-terminal half-transferrin in Pichia pastoris. Protein Expr. Purif.,1995, 6, 619-624.
8. Ouyang, J.; Wang, J.; Deng, R.; Long, Q.; Wang, X. High-levelexpression, purification, and characterization of porcine somatotropinin Pichia pastoris. Protein Expr. Purif., 2003, 32, 28-34.
9. Murasugi, A.; Tohma-Aiba, Y. Production of native recombinanthuman midkine in the yeast, Pichia pastoris. Protein Expr. Purif.,2003, 27, 244-252.
10. Gurkan, C.; Ellar, D.J. Expression in Pichia pastoris and purificationof a membrane-acting immunotoxin based on a synthetic genecoding for the Bacillus thuringiensis Cyt2Aa1 toxin. Protein Expr.Purif., 2003, 29, 103-116.
11. Kreusch, A.; Lesley, S.A. In: High-Throughput Cloning, Expressionand Purification Technologies, Grandi, G. eds., Genomics,Proteomics and Vaccines, John Wiley & Sons, Chichester, 2004;pp. 171-182.
12. Anicetti, V.R.; Fehskens, E.F.; Reed, B.R.; Chen, A.B.; Moore, P.; Geier, M.D.; Jones, A.J. Immunoassay for the detection of E. coliproteins in recombinant DNA derived human growth hormone. J.Immunol. Meth., 1986, 91, 213-224.
13. Merrick, H.; Hawlitschek, G. A complete system for quantitativeanalysis of total DNA, protein impurities and relevant proteins. Biotech Forum EU, 1992, 6, 398-403.
14. Chen, A.B.; Championsmith, A.A.; Blanchard, J.; Gorrell, J.; Niepelt, B.A.; Federici, M.M.; Formento, J;, Sinicropi, D.V. Quantitation of E. coli protein impurities in recombinant human interferon-gamma. Appl. Biochem. Biotechnol., 1992, 36, 137-152.
15. Eaton, L.C. Host cell contaminant protein assay development forrecombinant biopharmaceuticals. J. Chromatogr., 1995, 705, 105-114.
16. Dagoussat, N.; Haeuw, J.F.; Robillard, V.; Damien, F.; Libon, C.; Corvaia, N.; Lawny, F.; Nguyen, T.N.; Bonnefoy, J.Y.; Beck, A. Development of a quantitative assay for residual host cell proteinsin a recombinant subunit vaccine against human respiratory syncytialvirus. J. Immunol. Meth., 2001, 251, 151-159.
17. Wan, M.; Wang, Y.; Rabideau, S.; Moreadith, R.; Schrimsher, J.; Conn, G. An enzyme-linked immunosorbent assay for host cellprotein contaminants in recombinant PEGylated staphylokinasemutant SY161. J. Pharm. Biomed. Anal., 2002, 28, 953-963.
18. Phillips, M.; Cormier, J.; Ferrence, J.; Dowd, C.; Kiss, R.; Lutz, H.; Carter, J. Performance of a membrane adsorber for trace impurityremoval in biotechnology manufacturing. J. Chromatogr. A, 2005,1078, 74-82.
19. Laird, M.W.; Sampey, G.C.; Johnson, K.; Zukauskas, D.; Pierre, J.; Hong, J.S.; Cooksey, B.A.; Li, Y.; Galperina, O.; Karwoski, J.D.; Burke, R.N. Optimization of BLyS production and purificationfrom Escherichia coli. Protein Expr. Purif., 2005, 39, 237-246.
20. Miles, A.P.; Zhu, D.; Saul, A. Determining residual host cell antigenlevels in purified recombinant proteins by slot blot and scanninglaser densitometry. Methods Mol. Biol., 2005, 308, 233-242.
21. Zhu, D.; Saul, A.J.; Miles, A.P. A quantitative slot blot assay forhost cell protein impurities in recombinant proteins expressed in E.coli. J. Immunol. Methods, 2005, 306, 40-50.
22. Krawitz, D.C.; Forrest, W.; Moreno, G.T.; Kittleson, J.; Champion, K.M. Proteomic studies support the use of multi-product immunoassaysto monitor host cell protein impurities. Proteomics, 2006 6,94-110.
23. Yigzaw, Y.; Piper, R.; Tran, M.; Shukla, A.A. Exploitation of theadsorptive properties of depth filters for host cell protein removalduring monoclonal antibody purification. Biotechnol. Prog., 2006,22, 288-296.
24. Thulasiraman, V.; Lin, S.; Gheorghiu, L.; Lathrop, J.; Lomas, L.; Hammond, D.; Boschetti, E. Reduction of the concentration differenceof proteins in biological liquids using a library of combinatorialligands. Electrophoresis, 2005, 26, 3561-3571.
25. Righetti, P.G.; Boschetti, E.; Lomas L.; Citterio, A. Protein EqualizerTechnology: the quest for a democratic proteome. Proteomics,2006, 6, 3980-3992.
26. Guerrier, L.; Thulasiraman, V.; Castagna, A.; Fortis, F.; Lin, S.; Lomas, L.; Righetti, P.G.; Boschetti, E. Reducing protein concentrationrange of biological samples using solid-phase ligand libraries. J. Chromatogr. B, 2006, 833, 33-40.
27. Castagna, A.; Cecconi, D.; Sennels, L.; Rappsilber, J.; Guerrier, L.; Fortis, F.; Boschetti, E.; Lomas, L.; Righetti, P.G. Exploring thehidden human urinary proteome via ligand library beads. J. ProteomeRes., 2005, 4, 1917-1930.
28. Righetti, P.G.; Boschetti, E. Sherlock Holmes and the proteome-adetective story. FEBS J., 2007, 274, 897-905.
29. Boschetti, E.; Lomas, L.; Citterio, A.; Righetti, P.G. Romancing thehidden proteome, Anno Domini two zero zero seven. J. Chromatogr.A, 2007, 1153, 277-290.
30. Guerrier, L.; Righetti, P.G.; Boschetti E. Reduction of dynamicprotein concentration range of biological extracts for the discoveryof low-abundance proteins by means of hexapeptide ligand libraries.Nat. Protocol., 2008, 3, 883-890.
31. Sennels, L.; Salek, M.; Lomas, L.; Boschetti, E.; Righetti, P.G.; Rappsilber, J. Proteomic Analysis of Human Blood Serum UsingPeptide Library Beads. J. Proteome Res., 2007, 6, 4055-4062.
32. Roux-Dalvai, F.; Gonzalez de Peredo, A.; Simó, C.; Guerrier, L.; Bouyssié, D.; Zanella, A.; Citterio, A.; Burlet-Schiltz, O.; Boschetti E.; Righetti, P.G.; Monsarrat, B. Extensive analysis of the cytoplasmicproteome of human erythrocytes using the peptide ligandlibrary technology and advanced mass spectrometry. Mol. Cell Proteomics,2008, 7, 2254-2269.
33. Mouton-Barbosa, E.; Roux-Dalvai, F.; Bouyssié, D.; Berger, F.; Schmidt, E.; Righetti, P.G.; Guerrier, L.; Boschetti, E.; Burlet-Schiltz, O.; Gonzalez de Peredo, A.; Monsarrat, B. In depth explorationof cerebrospinal fluid by combining peptide ligand librarytreatment and label free protein quantification. Mol. Cell. Proteomics,2010, 9, 1006-1021.
34. D'Ambrosio, C.; Arena, S.; Scaloni, A.; Guerrier, L.; Boschetti, E.; Mendieta, M.E.; Citterio, A.; Righetti, P.G. Exploring the chickenegg white proteome with combinatorial peptide ligand libraries. J.Proteome Res. 2008, 7, 3461-3474
35. Farinazzo, A.; Restuccia, U.; Bachi, A.; Guerrier, L.; Fortis, F.; Boschetti, E.; Fasoli, E.; Citterio, A.; Righetti, P.G. Chicken eggyolk cytoplasmic proteome, mined via combinatorial peptide ligandlibraries. J. Chromatogr. A, 2009, 1216, 1241-1252.
36. D'Amato, A.; Bachi, A.; Fasoli, E.; Boschetti, E.; Peltre, G.; Sénéchal, H.; Righetti, P.G. In-depth exploration of cow's whey proteomevia combinatorial peptide ligand libraries. J. Proteome Res.,2009, 8, 3925-3936.
37. Calvete, J.J.; Fasoli, E.; Sanz, L.; Boschetti, E.; Righetti, P.G. Exploring the venom proteome of the western diamondback rattlesnake, Crotalus atrox, via snake venomics and combinatorial peptideligand library approaches. J. Proteome Res., 2009, 8, 3055-3067.
38. Fasoli, E.; Sanz, L.; Wagstaff, S.; Harrison, R.A.; Righetti, P.G.; Calvete, J.J. Exploring the venom proteome of the African puff adder,Bitis arietans, using a combinatorial peptide ligand library approachat different pHs. J. Proteomics, 2010, 73, 932-942.
39. D'Amato, A.; Bachi, A.; Fasoli, E.; Boschetti, E.; Peltre, G.; Sénéchal, H.; Sutra, J.P.; Citterio, A.; Righetti, P.G. In-depth explorationof Hevea brasiliensis latex proteome and hidden allergensvia combinatorial peptide ligand libraries. J. Proteomics, 2010, 73,1368-1380.
40. Bhopale, G. M.; Nanda, R. K. Recombinant DNA expressionproducts for human therapeutic use. Curr. Sci., 2005, 89, 614-622.
41. Fortis, F.; Guerrier, L.; Righetti, P.G.; Antonioli, P.; Boschetti, E. A new approach for the removal of protein impurities from purifiedbiologicals using combinatorial solid-phase ligand libraries. Electrophoresis,2006, 27, 3018-3027.
42. Fortis, F.; Guerrier, L.; Areces, L.B.; Antonioli, P.; Hayes, T.; Carrick, K.; Hammond, D.; Boschetti, E.; Righetti, P.G. A new approachfor the detection and identification of protein impurities usingcombinatorial solid phase ligand libraries. J. Proteome Res.,2006, 5, 2577-2585.
43. Antonioli, P.; Fortis, F.; Guerrier, L.; Rinalducci, S.; Zolla, L.; Righetti, P.G.; Boschetti, E. Capturing and amplifying impuritiesfrom purified recombinant monoclonal antibodies via peptide librarybeads: A proteomic study. Proteomics, 2007, 7, 1624-1633.
44. Stern, M.; Herrmann, R. Overview of monoclonal antibodies incancer therapy: present and promise. Crit. Rev. Oncol. Hematol.,2005, 54, 11-29.
45. Weber, P.; Steinhart, H.; Paschke, A. Determination of the bovinefood allergen casein in white wines by quantitative indirect ELISA,SDS-PAGE, Western Blot and imunostaining. J. Agric. FoodChem., 2009, 57, 8399-8405.
46. Wigand, P.; Tenzer, S.; Schild, H.; Decker H. Analysis of proteincomposition of red wine in comparison with rosé and white winesby electrophoresis and high pressure liquid chromatography- massspectrometry. J. Agric. Food Chem., 2009, 57, 4328-4333.
47. Cereda, A.; Kravchuk, A.V.; D'Amato, A.; Bachi, A.; Righetti, P.G. Proteomics of wine additives: mining for the invisible viacombinatorial peptide ligand libraries. J. Proteomics, 2010, 73,1732-1739.
48. Monaci, L.; Losito, I.; Palmisano, F.; Visconti A. Identification ofallergenic milk proteins markers in fined white wines by capillaryliquid chromatography-electrospray ionization-tandem mass spectrometry.J. Chromatogr. A, 2010, 1217, 4300-4305.
49. D'Amato, A.; Kravchuk, A. V.; Bachi, A.; Righetti, P.G. Noah'snectar: the proteome content of a glass of red wine. J Proteomics,2010, 73, 2370-2377.
50. Fasoli, E.; Aldini, G.; Regazzoni, L.; Kravchuk, A.V.; Citterio, A.; Righetti, P.G. Les Maîtres de l'Orge: the Proteome Content ofYour Beer Mug. J. Proteome Res., 2010, 9, 5262-5269.
51. Boschetti, E.; Righetti, P.G. The art of observing rare protein specieswith peptide libraries. Proteomics, 2009, 9, 1492-1510.
52. Righetti, P.G.; Boschetti, E.; Kravchuk, A.V.; Fasoli, E. The proteomebuccaneers: how to unearth your treasure chest via combinatorialpeptide ligand libraries. Expt. Rev. Proteomics, 2010, 7, 373-385.
53. Fasoli, E.; Farinazzo, A.; Sun, C.J.; Kravchuk, A.V.; Guerrier, L.; Fortis, F.; Boschetti, E.; Righetti PG. Interaction among proteinsand peptide libraries in proteome analysis: pH involvement for alarger capture of species. J. Proteomics, 2010, 73, 733-742.
54. Keidel, E.M.; Ribitsch, D.; Lottspeich, F. Equalizer technology -equal rights for disparate beads. Proteomics, 2010, 10, 1-10.
55. Lathrop, J.T.; Hayes, T.K.; Carrick, K.; Hammond, D.J. Raritygives a charm: evaluation of trace proteins in plasma and serum. Expert Rev. Proteomics, 2005, 2, 393-406.
56. Sarkar, J.; Soukharev, S.; Lathrop, J.T.; Hammond, D.J. Functionalidentification of novel activities: activity-based selection of proteinsfrom complete proteomes. Anal. Biochem., 2007, 365, 91-102.
57. Buettner, J. A.; Dadd, C. A.; Baumbach, G. A.; Masecar, B. L.; Hammond, D. J. Chemically derived peptide libraries: A new resinand methodology for lead identification. Int. J. Pept. Protein Res.,1996, 47, 70-83.
58. Pennington, M. E.; Lam, K. S.; Cress, A. E. The use of a combinatoriallibrary method to isolate human tumor cell adhesion peptides. Mol. Divers., 1996, 2, 19-28.
59. Bastek, P. D.; Land, J. M.; Baumbach, G. A.; Hammond, D. H.; Carbonell, R. G. Discovery of alpha-1-proteinase inhibitor bindingpeptide from the screening of a solid phase combinatorial library. Sep. Sci. Technol., 2000, 35, 1681-1706.
60. Kaufman, D. B.; Hentsch, M. E.; Baumbach, G. A.; Buettner, J. A. Affinity purification of fibrinogen using a ligand from a peptide library. Biotechnol. Bioengin., 2002, 77, 278-289.
61. Miyamoto, S.; Liu, R.; Hung, S.; Wang, X.; Lam, K. S. Screeningof a one bead-one compound combinatorial library for beta-actinidentifies molecules active toward Ramos B-lymphoma cells. Anal.Biochem., 2008, 374, 112-120.
62. Yang, H.; Gurgel, P.V.; Carbonell, R.G. Characterization of the Hexamer Peptide Affinity Ligands that Bind the Fc Region of HumanImmunoglobulin G. J. Chromatogr. A, 2009, 1216, 910-918.
63. Kay, B.K.; Kasanov, J.; Knight, S.; Kurakin, A. Convergent evolutionwith combinatorial peptides. FEBS Let., 2000, 480, 55-62.
64. Nigel, J.K.; Simpson, R. Solid-Phase Extraction: Principles, Techniques, and Applications, CRC Press, Boca Raton, 2000.
65. Wang, C.; Soice, NP.; Ramaswarmy, S.; Gagnon, BA.; Umana, J.; Cotoni, KA.; Bian, N.; Cheng, KS. Cored anion-exchange chromatographymedia for antibody flow-through purification. J. Chromatogr.,2007, 1155, 74-84.
66. Hearn, M.T.W. High-resolution reversed-phase chromatography, in Janson, J.C.; Rydén, L. Eds. Protein Purification, Wiley-VCH, New York, 1998, pp. 239-282.
67. van Holde, K. E.; Johnson, W. C.; Ho, P. S. Principles of Physical Biochemistry, Prentice Hall, Upper Saddle River, 1998, pp. 9-11.
68. Beaulieu, L.; Aomari, H.; Groleau, D.; Subirade, M. An improvedand simplified method for the large-scale purification ofpediocin PA-1 produced by Pediococcus acidilactici. Biotechnol.Appl. Biochem., 2006, 43, 77-84.
69. Gibert, S.; Bakalara, N.; Santarelli, X.; Three-step chromatographicpurification procedure for the production of a his-tag recombinantkinesin overexpressed in E. coli. J. Chromatogr., 2000, 737, 143-150.
70. Gomes, AG.; Azevzdo, AM.; Aires-Barros, MR.; Prazeres, DM.Clearance of host cell impurities from plasmid-containing lysatesby boronate adsorption. J. Chromatogr., 2010, 1217, 2262-2266.
71. Giddings, J.C: Unified Separation Science, Wiley-Interscience,New York, 1991.
72. Dean, P.D.G.; Johnson, W.S.; Middle, F.A. (Eds.) Affinity Chromatography:a Practical Approach, IRL Press, Oxford, 1985.
73. Zeiger, RS. Current issues with influenza vaccination in egg allergy.J. Allergy Clin. Immunol., 2002, 110, 834-840.
74. Marc, C. Large variation in ovalbumin content in six Europeaninfluenza vaccines. Pharmeur. Sci. Notes 2006, 1, 27-29.